ConductScience.org, home

Paper750109

Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography.

Juma FD and 3 others. Cancer Chemother Pharmacol, 1978. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography. Papers, record 750109. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/750109

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
3.09
iCite
Revised in PubMed
2019-08-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Juma FDF D
2Rogers HJH J
3Trounce JRJ R
4Bradbrook IDI D

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclophosphamideMajor topic
Aged
Chromatography, Gas
Flame Ionization
Humans
Kinetics
Male
Methods
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1872080Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans.Cancer Res1977https://conductscience.org/library/papers/872080PubMed
21277214Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.Cancer Treat Rep1976https://conductscience.org/library/papers/1277214PubMed
34436788Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens.J Pharm Sci1974https://conductscience.org/library/papers/4436788PubMed
45157730Pharmacokinetics of cyclophosphamide in man.Br J Pharmacol1971https://conductscience.org/library/papers/5157730PubMed
51277226Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography.Cancer Treat Rep1976https://conductscience.org/library/papers/1277226PubMed
64688880Clinical pharmacology of cyclophosphamide.Cancer Res1973https://conductscience.org/library/papers/4688880PubMed
74801657[Quantitative determination of alkylating cytostatics on TLC plate with 4-pyridinecarboxaldehyde-2-benzothiazolylhydrazone].Arzneimittelforschung1973https://conductscience.org/library/papers/4801657PubMed

Download CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
27721455Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.Cell Mol Immunol2017https://conductscience.org/library/papers/27721455PubMed
10803453Metabolism and pharmacokinetics of oxazaphosphorines.Clin Pharmacokinet2000https://conductscience.org/library/papers/10803453PubMed
8070218Ifosfamide clinical pharmacokinetics.Clin Pharmacokinet1994https://conductscience.org/library/papers/8070218PubMed
7628055High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7628055PubMed
7448105The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7448105PubMed
7362775Distribution and pharmacokinetics of cyclophosphamide in the rat.Br J Cancer1980https://conductscience.org/library/papers/7362775PubMed
7307230Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7307230PubMed
7250178Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7250178PubMed
7139850Biliary elimination of cyclophosphamide in man.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7139850PubMed
6882623Pharmacokinetics of cyclophosphamide in Kenyan Africans.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6882623PubMed
6743483Pharmacokinetics of cyclophosphamide in Kenyan African children with lymphoma.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6743483PubMed
6468474Effect of liver failure on the pharmacokinetics of cyclophosphamide.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6468474PubMed
3940219Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3940219PubMed
3757157Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3757157PubMed
3168149Disposition of ifosfamide in patients receiving ifosfamide infusion therapy for the treatment of cervical carcinoma.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3168149PubMed
3052986Clinical pharmacokinetics of drugs used in the treatment of breast cancer.Clin Pharmacokinet1988https://conductscience.org/library/papers/3052986PubMed
2842552The pharmacokinetics of high dose cyclophosphamide and high dose etoposide.Med Oncol Tumor Pharmacother1988https://conductscience.org/library/papers/2842552PubMed
2271371Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2271371PubMed
2245487Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2245487PubMed
2091018The risks of handling cytotoxic drugs. II. Recommendations for working with cytotoxic drugs.Pharm Weekbl Sci1990https://conductscience.org/library/papers/2091018PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/750109

GET https://conductscience.org/api/papers/v1/750109/cited_by?page=2